Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review.
<h4>Introduction</h4>Use of antiretroviral therapy (ART) during treatment of drug susceptible tuberculosis (TB) improves survival. However, data from HIV infected individuals with drug resistant TB are lacking. Second line TB drugs when combined with ART may increase drug interactions an...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0047370&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850121805883244544 |
|---|---|
| author | Matthew Arentz Patricia Pavlinac Michael E Kimerling David J Horne Dennis Falzon Holger J Schünemann Sarah Royce Keertan Dheda Judd L Walson ART study group |
| author_facet | Matthew Arentz Patricia Pavlinac Michael E Kimerling David J Horne Dennis Falzon Holger J Schünemann Sarah Royce Keertan Dheda Judd L Walson ART study group |
| author_sort | Matthew Arentz |
| collection | DOAJ |
| description | <h4>Introduction</h4>Use of antiretroviral therapy (ART) during treatment of drug susceptible tuberculosis (TB) improves survival. However, data from HIV infected individuals with drug resistant TB are lacking. Second line TB drugs when combined with ART may increase drug interactions and lead to higher rates of toxicity and greater noncompliance. This systematic review sought to determine the benefit of ART in the setting of second line drug therapy for drug resistant TB.<h4>Methods</h4>We included individual patient data from studies that evaluated treatment of drug-resistant tuberculosis in HIV-1 infected individuals published between January 1980 and December of 2009. We evaluated the effect of ART on treatment outcomes, time to smear and culture conversion, and adverse events.<h4>Results</h4>Ten observational studies, including data from 217 subjects, were analyzed. Patients using ART during TB treatment had increased likelihood of cure (hazard ratio (HR) 3.4, 95% CI 1.6-7.4) and decreased likelihood of death (HR 0.4, 95% CI 0.3-0.6) during treatment for drug resistant TB. These associations remained significant in patients with a CD4 less than 200 cells/mm(3) and less than 50 cells/mm(3), and when correcting for drug resistance pattern.<h4>Limitations</h4>We identified only observational studies from which individual patient data could be drawn. Limitations in study design, and heterogeneity in a number of the outcomes of interest had the potential to introduce bias.<h4>Discussion</h4>While there are insufficient data to determine if ART use increases adverse drug interactions when used with second line TB drugs, ART use during treatment of drug resistant TB appears to improve cure rates and decrease risk of death. All individuals with HIV appear to benefit from ART use during treatment for TB. |
| format | Article |
| id | doaj-art-27b965eee2bc410c8ad81b2c3eeb3432 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-27b965eee2bc410c8ad81b2c3eeb34322025-08-20T02:35:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01711e4737010.1371/journal.pone.0047370Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review.Matthew ArentzPatricia PavlinacMichael E KimerlingDavid J HorneDennis FalzonHolger J SchünemannSarah RoyceKeertan DhedaJudd L WalsonART study group<h4>Introduction</h4>Use of antiretroviral therapy (ART) during treatment of drug susceptible tuberculosis (TB) improves survival. However, data from HIV infected individuals with drug resistant TB are lacking. Second line TB drugs when combined with ART may increase drug interactions and lead to higher rates of toxicity and greater noncompliance. This systematic review sought to determine the benefit of ART in the setting of second line drug therapy for drug resistant TB.<h4>Methods</h4>We included individual patient data from studies that evaluated treatment of drug-resistant tuberculosis in HIV-1 infected individuals published between January 1980 and December of 2009. We evaluated the effect of ART on treatment outcomes, time to smear and culture conversion, and adverse events.<h4>Results</h4>Ten observational studies, including data from 217 subjects, were analyzed. Patients using ART during TB treatment had increased likelihood of cure (hazard ratio (HR) 3.4, 95% CI 1.6-7.4) and decreased likelihood of death (HR 0.4, 95% CI 0.3-0.6) during treatment for drug resistant TB. These associations remained significant in patients with a CD4 less than 200 cells/mm(3) and less than 50 cells/mm(3), and when correcting for drug resistance pattern.<h4>Limitations</h4>We identified only observational studies from which individual patient data could be drawn. Limitations in study design, and heterogeneity in a number of the outcomes of interest had the potential to introduce bias.<h4>Discussion</h4>While there are insufficient data to determine if ART use increases adverse drug interactions when used with second line TB drugs, ART use during treatment of drug resistant TB appears to improve cure rates and decrease risk of death. All individuals with HIV appear to benefit from ART use during treatment for TB.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0047370&type=printable |
| spellingShingle | Matthew Arentz Patricia Pavlinac Michael E Kimerling David J Horne Dennis Falzon Holger J Schünemann Sarah Royce Keertan Dheda Judd L Walson ART study group Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review. PLoS ONE |
| title | Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review. |
| title_full | Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review. |
| title_fullStr | Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review. |
| title_full_unstemmed | Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review. |
| title_short | Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review. |
| title_sort | use of anti retroviral therapy in tuberculosis patients on second line anti tb regimens a systematic review |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0047370&type=printable |
| work_keys_str_mv | AT matthewarentz useofantiretroviraltherapyintuberculosispatientsonsecondlineantitbregimensasystematicreview AT patriciapavlinac useofantiretroviraltherapyintuberculosispatientsonsecondlineantitbregimensasystematicreview AT michaelekimerling useofantiretroviraltherapyintuberculosispatientsonsecondlineantitbregimensasystematicreview AT davidjhorne useofantiretroviraltherapyintuberculosispatientsonsecondlineantitbregimensasystematicreview AT dennisfalzon useofantiretroviraltherapyintuberculosispatientsonsecondlineantitbregimensasystematicreview AT holgerjschunemann useofantiretroviraltherapyintuberculosispatientsonsecondlineantitbregimensasystematicreview AT sarahroyce useofantiretroviraltherapyintuberculosispatientsonsecondlineantitbregimensasystematicreview AT keertandheda useofantiretroviraltherapyintuberculosispatientsonsecondlineantitbregimensasystematicreview AT juddlwalson useofantiretroviraltherapyintuberculosispatientsonsecondlineantitbregimensasystematicreview AT artstudygroup useofantiretroviraltherapyintuberculosispatientsonsecondlineantitbregimensasystematicreview |